EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

NUB1 Regulates Muscle Atrophy in Lung Cancer Cachexia via NF‐κB Signaling Pathway

Yuqi Han iD, Yaru Xia, Weiquan Li, Jiaming Wu, Tiexi Yu, Diaoyi Tan, Daojia Miao iD, Wen Li, Xuejiao Dong, Jiemin Li, Yu Jiao, Guixiao Huang and 2 more

Advanced Science · 2026-10-31

DOI: 10.1002/advs.78492 ↗

At a glance

Journal article in Advanced Science, published online on 2026-10-31. Written by Yuqi Han and 13 co-authors. Institution: Department of Pathogenic Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 72 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Shenzhen Medical Research Fund, Sanming Project of Medicine in Shenzhen.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Cancer‐associated cachexia (CAC) is a devastating multifactorial syndrome characterized by progressive skeletal muscle atrophy. Its mechanisms remain incompletely clarified, with limited effective therapeutic targets. NUB1, a negative regulator of ubiquitin‐like proteins mediating protein degradation, has not been fully elucidated in CAC‐induced muscle atrophy. Here, NUB1 was significantly upregulated in skeletal muscles of Lewis lung carcinoma (LLC) cachexia mice and C2C12 myotube atrophy models stimulated with LLC tumor‐conditioned medium (LCM). Silencing NUB1 alleviated LCM‐induced myotube atrophy in vitro and enhanced muscle mass, fiber cross‐sectional area and function in LLC cachectic mice in vivo . Mechanistically, upregulated NUB1 recruited IκBα to bind proteasomal subunit S5a, promoting IκBα degradation, thus increasing NF‐κB nuclear translocation and transcription of Atrogin1 and MuRF1 . Silencing NUB1 inhibited NF‐κB activation, while TNFα reversed its protective effect. These findings identified NUB1 as a novel driver of CAC‐related muscle atrophy and highlighted the NUB1/IκBα/NF‐κB axis as a promising therapeutic target.

Subjects

Author keywords

NF‐κB signalingNUB1cancer‐associated cachexiamuscle atrophy

Authors and institutions

  • Department of Pathogenic Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Institute of Urology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Urology, The Third Affiliated Hospital of Shenzhen University: Shenzhen Luohu Hospital Group Luohu People's Hospital, Shenzhen, China.
  • Shenzhen Huazhong University of Science and Technology Research Institute, Shenzhen, China.

ORCID profiles: Yuqi Han, Daojia Miao, Xiaoping Zhang, Hongmei Yang

Funding

  • National Natural Science Foundation of China
  • Shenzhen Medical Research Fund
  • Sanming Project of Medicine in Shenzhen

Cite

APA

Han, Y., Xia, Y., Li, W., Wu, J., Yu, T., Tan, D., Miao, D., Li, W., Dong, X., Li, J., Jiao, Y., Huang, G., Zhang, X., & Yang, H. (2026). NUB1 Regulates Muscle Atrophy in Lung Cancer Cachexia via NF‐κB Signaling Pathway. Advanced Science. https://doi.org/10.1002/advs.78492

Vancouver

Han Y, Xia Y, Li W, Wu J, Yu T, Tan D, et al. NUB1 Regulates Muscle Atrophy in Lung Cancer Cachexia via NF‐κB Signaling Pathway. Advanced Science. 2026. doi:10.1002/advs.78492

BibTeX
@article{Han2026,
  author = {Han, Yuqi and Xia, Yaru and Li, Weiquan and Wu, Jiaming and Yu, Tiexi and Tan, Diaoyi and Miao, Daojia and Li, Wen and Dong, Xuejiao and Li, Jiemin and Jiao, Yu and Huang, Guixiao and Zhang, Xiaoping and Yang, Hongmei},
  title = {NUB1 Regulates Muscle Atrophy in Lung Cancer Cachexia via NF‐κB Signaling Pathway},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78492}
}
Start for free →